-
Diagnostics World News I New diagnostic assay allows testing and genomic surveillance simultaneously, a portable and bifunctional electrical detector for SARS-CoV-2, 1 in 3 infected asymptomatic. Plus: Melatonin produced in lungs could be used as a prognostic biomarker and machine learning predicts COVID-19 patient outcomes.
Jan 29, 2021
-
Diagnostics World News | Saliva for early lunch cancer detection, new guidelines for diagnosis of bleeding disorder, Babson claims fingerstick diagnostics in a retail setting, and looking at Alzheimer’s. Plus: companion diagnostic agreements, and genomic sequencing for prenatal testing.
Jan 28, 2021
-
Diagnostics World News | Moffitt Cancer Center researchers have discovered a way to pinpoint a subset of prostate cancer patients with aggressive tumors who may benefit from combined immune-radiotherapy modalities. The answer gets computed from a combination of the immune content score (ICS) and the 22-gene Decipher classifier score that is predictive of metastasis.
Jan 25, 2021
-
Diagnostics World News | Quantified smell loss the best predictor of COVID-19 among those with symptoms, the outlook for self-tests, circulating mitochondria as a warning of severe disease, and more. Plus: QIAGEN’s PCR test stands up to new variants, new development on tests to distinguish between SARS-CoV-2 and influenza.
Jan 22, 2021
-
Diagnostics World News | Cancer tries its hardest not to be found. Seeking to better understand the early tumor micro-environment may prove to be a powerful harbinger of early cancer development. In our quest for early cancer detection, we should look more closely at the complex and potentially detectable changes in the micro-environment surrounding the tumor.
Jan 19, 2021